• 1.廣西醫(yī)科大學(xué)附屬腫瘤醫(yī)院普瘤科（南寧530021）;;
  • 2.廣西醫(yī)科大學(xué)附屬腫瘤醫(yī)院細(xì)胞研究室;

可溶性P選擇素可抑制多形核中性粒細(xì)胞通過整合素CD11b與血管內(nèi)皮細(xì)胞粘附，有明顯的控制炎癥的作用［1］，也可介導(dǎo)某些腫瘤細(xì)胞與內(nèi)皮細(xì)胞的粘附［2］，與腫瘤的發(fā)展和轉(zhuǎn)移有關(guān)。為探討血漿可溶性P選擇素水平在乳腺癌患者手術(shù)前后的變化及意義，我們檢測(cè)了42例乳腺癌患者手術(shù)前后血漿可溶性P選擇素水平，現(xiàn)報(bào)道如下。
1資料與方法
正常對(duì)照組36例，男女各18例，年齡23~55歲，平均37.6歲，系健康體檢者，于早晨取空腹靜脈血。乳腺癌組42例，年齡27～68歲，平均47.6歲，均為臨床Ⅱ期患者，并行根治性手術(shù)，其中行乳腺癌根治術(shù)15例，乳腺癌改良根治術(shù)27例。組織學(xué)類型： 單純癌29例，浸潤(rùn)性導(dǎo)管癌5例，髓樣癌3例，硬癌3例，粘液腺癌2例。分別于術(shù)前1 d、術(shù)后第1 d、15 d和30 d早晨取空腹靜脈血，應(yīng)用可溶性P選擇素ELISA試劑盒（蘇州醫(yī)學(xué)院血栓病研究所提供）檢測(cè)血漿可溶性P選擇素。所得數(shù)據(jù)用±s表示，用t檢驗(yàn)和方差分析進(jìn)行組間比較。

引用本文： 劉劍勇,高月芳,覃宇周,吳飛翔,張力圖,唐朝暉,李挺,楊南武. 乳腺癌患者手術(shù)前后血漿可溶性P選擇素的檢測(cè)及意義△. 中國(guó)普外基礎(chǔ)與臨床雜志, 2002, 9(2): 121-121. doi: 復(fù)制

1. Gamble JR, Skinner MP, Bendall LJ, et al. Characterization of GMP140(Pselectin)as a circulating plasma protein [J].J Exp Med, 1992; 175(4)∶1147.
2. Pottratz ST, Hall TD, Scribner WM, et al. Pselectin mediated attachment of small cell lung carcinoma to endothelian cells [J]. Am J Physiol, 1996; 217(5)∶ L918.
3. Fox SB, Turner GD, Gatter KC, et al. The increased expression of adhesion molecules ICAM3, E and Pselectin on breast cancer endothelium [J].J Pathol, 1995; 177(4)∶369.
4. Moor KL, Patel KD, Bruehl RE, et al. Pselectin glycoprotein ligand1 mediates rolling of human neutrophils on Pselectin [J].J Cell Biol, 1995; 128(3)∶ 661.
5. Brock TA, Dvorak HF, Senger DR, et al. Tumorsecreted vascular permeability factor increase cytosolic Ca++and von Willebrand factor release in human endothelial cells [J]. Am J Pathol, 1995; 138(3)∶213.
6. Vaki A. Selectins ligands [J]. Proc Natl Acad Sci USA, 1994; 91(23)∶7390.
7. 周同，陳曉，陳金聯(lián)，等. P選擇素在胃癌、腎癌中表達(dá)及其臨床意義 [J]. 中華醫(yī)學(xué)雜志， 1997； 77（7）∶530.
8. Schadendorf D, Diehl S, Zuberbier T, et al. Quantitative detection of soluble adhesion molecules in sera melanoma patients correlates with clinical stage [J]. Dermatology, 1996; 192(2)∶89.
  1. 1. Gamble JR, Skinner MP, Bendall LJ, et al. Characterization of GMP140(Pselectin)as a circulating plasma protein [J].J Exp Med, 1992; 175(4)∶1147.
  2. 2. Pottratz ST, Hall TD, Scribner WM, et al. Pselectin mediated attachment of small cell lung carcinoma to endothelian cells [J]. Am J Physiol, 1996; 217(5)∶ L918.
  3. 3. Fox SB, Turner GD, Gatter KC, et al. The increased expression of adhesion molecules ICAM3, E and Pselectin on breast cancer endothelium [J].J Pathol, 1995; 177(4)∶369.
  4. 4. Moor KL, Patel KD, Bruehl RE, et al. Pselectin glycoprotein ligand1 mediates rolling of human neutrophils on Pselectin [J].J Cell Biol, 1995; 128(3)∶ 661.
  5. 5. Brock TA, Dvorak HF, Senger DR, et al. Tumorsecreted vascular permeability factor increase cytosolic Ca++and von Willebrand factor release in human endothelial cells [J]. Am J Pathol, 1995; 138(3)∶213.
  6. 6. Vaki A. Selectins ligands [J]. Proc Natl Acad Sci USA, 1994; 91(23)∶7390.
  7. 7. 周同，陳曉，陳金聯(lián)，等. P選擇素在胃癌、腎癌中表達(dá)及其臨床意義 [J]. 中華醫(yī)學(xué)雜志， 1997； 77（7）∶530.
  8. 8. Schadendorf D, Diehl S, Zuberbier T, et al. Quantitative detection of soluble adhesion molecules in sera melanoma patients correlates with clinical stage [J]. Dermatology, 1996; 192(2)∶89.